benzonatate
- Product NDC
- 53002-0410
- 11-digit product format
- 530020410
- Labeler code
- 53002
- Product ID
- 53002-0410_a044f0bb-7b2b-46c1-856b-4f8a999ee5cf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- benzonatate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA040749
- Marketing category
- ANDA
- Marketing start
- 2007-07-25
- Marketing end
- 0000-00-00
- Substance
- BENZONATATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53002-0410-1 | 2020-12-15 | C162847 | 48780-1 | 9d75b9d0-c6f1-f424-e053-dadaa90a57ce | 798c2d3f-6ebb-4b95-85f3-525693379d48 |
| 53002-0410-2 | 2020-12-15 | C162847 | 48780-1 | 9d75b9d0-c6f1-f424-e053-dadaa90a57ce | 798c2d3f-6ebb-4b95-85f3-525693379d48 |
| 53002-0410-3 | 2020-12-15 | C162847 | 48780-1 | 9d75b9d0-c6f1-f424-e053-dadaa90a57ce | 798c2d3f-6ebb-4b95-85f3-525693379d48 |
| 53002-0410-4 | 2020-12-15 | C162847 | 48780-1 | 9d75b9d0-c6f1-f424-e053-dadaa90a57ce | 798c2d3f-6ebb-4b95-85f3-525693379d48 |
| 53002-0410-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-c6f1-f424-e053-dadaa90a57ce | 798c2d3f-6ebb-4b95-85f3-525693379d48 |
| 53002-0410-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-c6f1-f424-e053-dadaa90a57ce | 798c2d3f-6ebb-4b95-85f3-525693379d48 |
| 53002-0410-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-c6f1-f424-e053-dadaa90a57ce | 798c2d3f-6ebb-4b95-85f3-525693379d48 |
| 53002-0410-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-c6f1-f424-e053-dadaa90a57ce | 798c2d3f-6ebb-4b95-85f3-525693379d48 |